ID   HECW2_HUMAN             Reviewed;        1572 AA.
AC   Q9P2P5; B8ZZB4; Q17RT5; Q68DF8; Q9NPS9;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 2.
DT   15-MAR-2017, entry version 128.
DE   RecName: Full=E3 ubiquitin-protein ligase HECW2;
DE            EC=2.3.2.26;
DE   AltName: Full=HECT, C2 and WW domain-containing protein 2;
DE   AltName: Full=HECT-type E3 ubiquitin transferase HECW2;
DE   AltName: Full=NEDD4-like E3 ubiquitin-protein ligase 2;
GN   Name=HECW2; Synonyms=KIAA1301, NEDL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1352-1572 (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Heart, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, INTERACTION WITH TP73, AND TISSUE SPECIFICITY.
RX   PubMed=12890487; DOI=10.1016/S0006-291X(03)01347-0;
RA   Miyazaki K., Ozaki T., Kato C., Hanamoto T., Fujita T., Irino S.,
RA   Watanabe K., Nakagawa T., Nakagawara A.;
RT   "A novel HECT-type E3 ubiquitin ligase, NEDL2, stabilizes p73 and
RT   enhances its transcriptional activity.";
RL   Biochem. Biophys. Res. Commun. 308:106-113(2003).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH FZR1, AND
RP   UBIQUITINATION.
RX   PubMed=24163370; DOI=10.1074/jbc.M113.472076;
RA   Lu L., Hu S., Wei R., Qiu X., Lu K., Fu Y., Li H., Xing G., Li D.,
RA   Peng R., He F., Zhang L.;
RT   "The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-
RT   promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation
RT   maintains the metaphase to anaphase transition.";
RL   J. Biol. Chem. 288:35637-35650(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48; SER-852 AND SER-909,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1175, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   INVOLVEMENT IN NDHSAL, AND VARIANTS NDHSAL GLN-1191; VAL-1193;
RP   TRP-1330 AND GLY-1445.
RX   PubMed=27389779; DOI=10.1136/jmedgenet-2016-103943;
RA   Berko E.R., Cho M.T., Eng C., Shao Y., Sweetser D.A., Waxler J.,
RA   Robin N.H., Brewer F., Donkervoort S., Mohassel P., Boennemann C.G.,
RA   Bialer M., Moore C., Wolfe L.A., Tifft C.J., Shen Y., Retterer K.,
RA   Millan F., Chung W.K.;
RT   "De novo missense variants in HECW2 are associated with
RT   neurodevelopmental delay and hypotonia.";
RL   J. Med. Genet. 54:84-86(2017).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination
CC       of TP73. Acts to stabilize TP73 and enhance activation of
CC       transcription by TP73 (PubMed:12890487). Involved in the
CC       regulation of mitotic metaphase/anaphase transition
CC       (PubMed:24163370). {ECO:0000269|PubMed:12890487,
CC       ECO:0000269|PubMed:24163370}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with TP73 (PubMed:12890487). Interacts with
CC       FZR1 (PubMed:24163370). {ECO:0000269|PubMed:12890487,
CC       ECO:0000269|PubMed:24163370}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm,
CC       cytoskeleton, spindle {ECO:0000269|PubMed:24163370}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9P2P5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9P2P5-2; Sequence=VSP_023077;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in adult brain, lung
CC       and heart. {ECO:0000269|PubMed:12890487}.
CC   -!- PTM: Ubiquitinated and degraded during mitotic exit by APC/C-Cdh1.
CC       {ECO:0000269|PubMed:24163370}.
CC   -!- DISEASE: Neurodevelopmental disorder with hypotonia, seizures, and
CC       absent language (NDHSAL) [MIM:617268]: A neurodevelopmental
CC       disorder characterized by severely delayed psychomotor
CC       development, absent speech, epilepsy, encephalopathy, hypotonia,
CC       dystonia/dyskinesia, and macrocephaly. Brain imaging show cerebral
CC       atrophy, enlarged ventricles, and white matter abnormalities.
CC       {ECO:0000269|PubMed:27389779}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92539.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB037722; BAA92539.1; ALT_INIT; mRNA.
DR   EMBL; AL390186; CAB99103.1; -; mRNA.
DR   EMBL; CR749424; CAH18262.1; -; mRNA.
DR   EMBL; AC020571; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068544; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073905; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC074090; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093379; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC117194; AAI17195.1; -; mRNA.
DR   EMBL; BC117198; AAI17199.1; -; mRNA.
DR   CCDS; CCDS33354.1; -. [Q9P2P5-1]
DR   CCDS; CCDS77499.1; -. [Q9P2P5-2]
DR   PIR; T51886; T51886.
DR   RefSeq; NP_001291769.1; NM_001304840.1. [Q9P2P5-2]
DR   RefSeq; NP_065811.1; NM_020760.2. [Q9P2P5-1]
DR   RefSeq; XP_016860052.1; XM_017004563.1. [Q9P2P5-1]
DR   UniGene; Hs.654742; -.
DR   PDB; 2LFE; NMR; -; A=43-162.
DR   PDBsum; 2LFE; -.
DR   ProteinModelPortal; Q9P2P5; -.
DR   SMR; Q9P2P5; -.
DR   BioGrid; 121581; 294.
DR   IntAct; Q9P2P5; 1.
DR   MINT; MINT-2820726; -.
DR   STRING; 9606.ENSP00000260983; -.
DR   iPTMnet; Q9P2P5; -.
DR   PhosphoSitePlus; Q9P2P5; -.
DR   BioMuta; HECW2; -.
DR   DMDM; 126215718; -.
DR   EPD; Q9P2P5; -.
DR   MaxQB; Q9P2P5; -.
DR   PaxDb; Q9P2P5; -.
DR   PeptideAtlas; Q9P2P5; -.
DR   PRIDE; Q9P2P5; -.
DR   Ensembl; ENST00000260983; ENSP00000260983; ENSG00000138411. [Q9P2P5-1]
DR   Ensembl; ENST00000409111; ENSP00000386775; ENSG00000138411. [Q9P2P5-2]
DR   GeneID; 57520; -.
DR   KEGG; hsa:57520; -.
DR   UCSC; uc002utl.2; human. [Q9P2P5-1]
DR   CTD; 57520; -.
DR   DisGeNET; 57520; -.
DR   GeneCards; HECW2; -.
DR   HGNC; HGNC:29853; HECW2.
DR   HPA; HPA034609; -.
DR   MIM; 617245; gene.
DR   MIM; 617268; phenotype.
DR   neXtProt; NX_Q9P2P5; -.
DR   OpenTargets; ENSG00000138411; -.
DR   PharmGKB; PA134925001; -.
DR   eggNOG; KOG0940; Eukaryota.
DR   eggNOG; COG5021; LUCA.
DR   GeneTree; ENSGT00760000118966; -.
DR   HOGENOM; HOG000069940; -.
DR   HOVERGEN; HBG057414; -.
DR   InParanoid; Q9P2P5; -.
DR   KO; K12168; -.
DR   OMA; PTDTRLS; -.
DR   OrthoDB; EOG091G0A54; -.
DR   PhylomeDB; Q9P2P5; -.
DR   TreeFam; TF313938; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q9P2P5; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; HECW2; human.
DR   GenomeRNAi; 57520; -.
DR   PRO; PR:Q9P2P5; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000138411; -.
DR   CleanEx; HS_HECW2; -.
DR   ExpressionAtlas; Q9P2P5; baseline and differential.
DR   Genevisible; Q9P2P5; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IEA:InterPro.
DR   GO; GO:0030071; P:regulation of mitotic metaphase/anaphase transition; IMP:UniProtKB.
DR   CDD; cd00078; HECTc; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR000569; HECT_dom.
DR   InterPro; IPR032348; HECW_N.
DR   InterPro; IPR001202; WW_dom.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00632; HECT; 1.
DR   Pfam; PF16562; HECW_N; 1.
DR   Pfam; PF00397; WW; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00119; HECTc; 1.
DR   SMART; SM00456; WW; 2.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF51045; SSF51045; 2.
DR   SUPFAM; SSF56204; SSF56204; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS50237; HECT; 1.
DR   PROSITE; PS01159; WW_DOMAIN_1; 2.
DR   PROSITE; PS50020; WW_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Disease mutation; Phosphoprotein;
KW   Reference proteome; Repeat; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   CHAIN         1   1572       E3 ubiquitin-protein ligase HECW2.
FT                                /FTId=PRO_0000277667.
FT   DOMAIN      172    282       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      807    840       WW 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00224}.
FT   DOMAIN      985   1018       WW 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00224}.
FT   DOMAIN     1237   1572       HECT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00104}.
FT   REGION      737   1068       Interaction with TP73.
FT                                {ECO:0000269|PubMed:12890487}.
FT   COILED      847    874       {ECO:0000255}.
FT   ACT_SITE   1540   1540       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00104}.
FT   MOD_RES      48     48       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     852    852       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     909    909       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1175   1175       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1    356       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_023077.
FT   VARIANT    1191   1191       R -> Q (in NDHSAL).
FT                                {ECO:0000269|PubMed:27389779}.
FT                                /FTId=VAR_077905.
FT   VARIANT    1193   1193       F -> V (in NDHSAL).
FT                                {ECO:0000269|PubMed:27389779}.
FT                                /FTId=VAR_077906.
FT   VARIANT    1330   1330       R -> W (in NDHSAL).
FT                                {ECO:0000269|PubMed:27389779}.
FT                                /FTId=VAR_077907.
FT   VARIANT    1445   1445       E -> G (in NDHSAL).
FT                                {ECO:0000269|PubMed:27389779}.
FT                                /FTId=VAR_077908.
FT   CONFLICT   1074   1074       Q -> H (in Ref. 2; CAH18262).
FT                                {ECO:0000305}.
FT   STRAND       60     64       {ECO:0000244|PDB:2LFE}.
FT   STRAND       66     69       {ECO:0000244|PDB:2LFE}.
FT   STRAND       76     81       {ECO:0000244|PDB:2LFE}.
FT   STRAND       91     96       {ECO:0000244|PDB:2LFE}.
FT   STRAND      117    123       {ECO:0000244|PDB:2LFE}.
FT   STRAND      133    144       {ECO:0000244|PDB:2LFE}.
FT   TURN        145    148       {ECO:0000244|PDB:2LFE}.
FT   STRAND      149    153       {ECO:0000244|PDB:2LFE}.
FT   STRAND      157    160       {ECO:0000244|PDB:2LFE}.
SQ   SEQUENCE   1572 AA;  175769 MW;  DCFF0146ADFAF8BE CRC64;
     MASSAREHLL FVRRRNPQMR YTLSPENLQS LAAQSSMPEN MTLQRANSDT DLVTSESRSS
     LTASMYEYTL GQAQNLIIFW DIKEEVDPSD WIGLYHIDEN SPANFWDSKN RGVTGTQKGQ
     IVWRIEPGPY FMEPEIKICF KYYHGISGAL RATTPCITVK NPAVMMGAEG MEGGASGNLH
     SRKLVSFTLS DLRAVGLKKG MFFNPDPYLK MSIQPGKKSS FPTCAHHGQE RRSTIISNTT
     NPIWHREKYS FFALLTDVLE IEIKDKFAKS RPIIKRFLGK LTIPVQRLLE RQAIGDQMLS
     YNLGRRLPAD HVSGYLQFKV EVTSSVHEDA SPEAVGTILG VNSVNGDLGS PSDDEDMPGS
     HHDSQVCSNG PVSEDSAADG TPKHSFRTSS TLEIDTEELT STSSRTSPPR GRQDSLNDYL
     DAIEHNGHSR PGTATCSERS MGASPKLRSS FPTDTRLNAM LHIDSDEEDH EFQQDLGYPS
     SLEEEGGLIM FSRASRADDG SLTSQTKLED NPVENEEAST HEAASFEDKP ENLPELAESS
     LPAGPAPEEG EGGPEPQPSA DQGSAELCGS QEVDQPTSGA DTGTSDASGG SRRAVSETES
     LDQGSEPSQV SSETEPSDPA RTESVSEAST RPEGESDLEC ADSSCNESVT TQLSSVDTRC
     SSLESARFPE TPAFSSQEEE DGACAAEPTS SGPAEGSQES VCTAGSLPVV QVPSGEDEGP
     GAESATVPDQ EELGEVWQRR GSLEGAAAAA ESPPQEEGSA GEAQGTCEGA TAQEEGATGG
     SQANGHQPLR SLPSVRQDVS RYQRVDEALP PNWEARIDSH GRIFYVDHVN RTTTWQRPTA
     PPAPQVLQRS NSIQQMEQLN RRYQSIRRTM TNERPEENTN AIDGAGEEAD FHQASADFRR
     ENILPHSTSR SRITLLLQSP PVKFLISPEF FTVLHSNPSA YRMFTNNTCL KHMITKVRRD
     THHFERYQHN RDLVGFLNMF ANKQLELPRG WEMKHDHQGK AFFVDHNSRT TTFIDPRLPL
     QSSRPTSALV HRQHLTRQRS HSAGEVGEDS RHAGPPVLPR PSSTFNTVSR PQYQDMVPVA
     YNDKIVAFLR QPNIFEILQE RQPDLTRNHS LREKIQFIRT EGTPGLVRLS SDADLVMLLS
     LFEEEIMSYV PPHALLHPSY CQSPRGSPVS SPQNSPGTQR ANARAPAPYK RDFEAKLRNF
     YRKLETKGYG QGPGKLKLII RRDHLLEDAF NQIMGYSRKD LQRNKLYVTF VGEEGLDYSG
     PSREFFFLVS RELFNPYYGL FEYSANDTYT VQISPMSAFV DNHHEWFRFS GRILGLALIH
     QYLLDAFFTR PFYKALLRIL CDLSDLEYLD EEFHQSLQWM KDNDIHDILD LTFTVNEEVF
     GQITERELKP GGANIPVTEK NKKEYIERMV KWRIERGVVQ QTESLVRGFY EVVDARLVSV
     FDARELELVI AGTAEIDLSD WRNNTEYRGG YHDNHIVIRW FWAAVERFNN EQRLRLLQFV
     TGTSSIPYEG FASLRGSNGP RRFCVEKWGK ITALPRAHTC FNRLDLPPYP SFSMLYEKLL
     TAVEETSTFG LE
//
